These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 3802423)
21. The effects of H1 and H2 histamine receptor antagonists on the development of endotoxemia in the conscious, unrestrained rat. Brackett DJ; Schaefer CF; Wilson MF Circ Shock; 1985; 16(2):141-53. PubMed ID: 2414028 [TBL] [Abstract][Full Text] [Related]
22. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat. Salari H; Demos M; Wong A Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677 [TBL] [Abstract][Full Text] [Related]
23. PAF, rather than histamine, participates in mouse anaphylactic hypotension. Shibamoto T; Liu W; Cui S; Zhang W; Takano H; Kurata Y Pharmacology; 2008; 82(2):114-20. PubMed ID: 18583921 [TBL] [Abstract][Full Text] [Related]
24. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988. Issekutz AC; Szpejda M Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199 [TBL] [Abstract][Full Text] [Related]
26. Phenylephrine ameliorates cerebral cytotoxic edema and reduces cerebral infarction volume in a rat model of complete unilateral carotid artery occlusion with severe hypotension. Ishikawa S; Ito H; Yokoyama K; Makita K Anesth Analg; 2009 May; 108(5):1631-7. PubMed ID: 19372348 [TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal plasma leakage in endotoxic shock. Inhibition by prostaglandin E2 and by a platelet-activating factor antagonist. Wallace JL; Steel G; Whittle BJ Can J Physiol Pharmacol; 1987 Jul; 65(7):1428-32. PubMed ID: 3478114 [TBL] [Abstract][Full Text] [Related]
28. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock. Terashita Z; Imura Y; Nishikawa K; Sumida S Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():715-7. PubMed ID: 3004156 [No Abstract] [Full Text] [Related]
29. Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist). Misawa M; Chiba Y Res Commun Chem Pathol Pharmacol; 1994 Jun; 84(3):341-9. PubMed ID: 7938906 [TBL] [Abstract][Full Text] [Related]
30. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees. Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055 [TBL] [Abstract][Full Text] [Related]
31. Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies. Fernández-Gallardo S; Ortega MP; Priego JG; de Casa-Juana MF; Sunkel C; Sánchez Crespo M J Pharmacol Exp Ther; 1990 Oct; 255(1):34-9. PubMed ID: 2170626 [TBL] [Abstract][Full Text] [Related]
32. Platelet activating factor impairs pressor responses to noradrenaline in the anaesthetized rat but does not mediate endotoxin-induced hyporeactivity. Bouvier C; Guc MO; Furman BL; Parratt JR Circ Shock; 1994 Jan; 42(1):14-9. PubMed ID: 8149505 [TBL] [Abstract][Full Text] [Related]
33. [Effect of an extract from the cauline of Piper kadsura ohwi on endotoxin-induced hypotension and lung injury in rats]. Li SH; Fei X; Wu ZL; Cheng SF Zhongguo Zhong Yao Za Zhi; 1989 Nov; 14(11):683-5, 704. PubMed ID: 2619897 [TBL] [Abstract][Full Text] [Related]
34. Effect of LTB4 receptor antagonists in endotoxic shock in the rat. Li EJ; Cook JA; Wise WC; Jackson WT; Halushka PV Circ Shock; 1991 Aug; 34(4):385-92. PubMed ID: 1663429 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Effects on microvascular permeability, hypotension and nephrosis. Sakuma Y; Shirato M; Nagaoka J; Obaishi H; Tsunoda H; Katayama S; Ono H; Katayama K Arzneimittelforschung; 1991 Dec; 41(12):1255-9. PubMed ID: 1815526 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular responses to exogenous platelet-activating factor (PAF) in anesthetized ponies, and the effects of a PAF antagonist, WEB 2086. Wilson DV; Eberhart SW; Robinson NE; Rice R; Gray PR Am J Vet Res; 1993 Feb; 54(2):274-9. PubMed ID: 8430938 [TBL] [Abstract][Full Text] [Related]
37. Endotoxic shock elicits greater endorphin secretion than hemorrhage. Hamilton AJ; Carr DB; LaRovere JM; Black PM Circ Shock; 1986; 19(1):47-54. PubMed ID: 2941182 [TBL] [Abstract][Full Text] [Related]
38. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride. Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697 [TBL] [Abstract][Full Text] [Related]
39. Effects of palmitoyl carnitine and structural analogs on arterial blood pressure in the rat. A comparison with platelet-activating factor. Man RY; Hu WM; Mock T; Kinnaird AA J Lipid Mediat; 1991; 3(2):205-14. PubMed ID: 1686730 [TBL] [Abstract][Full Text] [Related]
40. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]